Suitable for supporting your internal and external presentations with reliable high quality data and analysisīiotechnology reagents refer to chemical compounds that are used in detecting, measuring, and preparing a product, and others by facilitating chemical. Understand customers based on the latest market shares.īenchmark performance against key competitors.
Sigma aldrich drivers#
Outperform competitors using forecast data and the drivers and trends shaping the market. Measure the impact of high global inflation on market growth.Ĭreate regional and country strategies on the basis of local data and analysis. Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.Īssess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market. Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. Major players in the biotechnology reagents market are Life Technologies Corporation, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Water Corporation, Sigma-Aldrich, Agilent Technologies Inc., Becton Dickinson and Company, Beckman Coulter Inc., Roche Holding AG, Abbott Laboratories, General Electric incorporated, PerkinElmer Inc., Merck Group, bioMerieux SA, Siemens Healthineers AG, Lonza Group, Hoefer Inc., Quality Biological Inc., Tosoh Corporation, Promega Corporation, Bio-Techne Corporation, Takara Bio Inc., and Sysmex Corporation. The biotechnology reagents market is expected to grow to $110.93 billion in 2027 at a CAGR of 9.0%.
The global biotechnology reagents market is expected to grow from $72.01 billion in 2022 to $78.47 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. This report provides strategists, marketers and senior management with the critical information they need to assess the market. Dublin, (GLOBE NEWSWIRE) - The "Biotechnology Reagents Global Market Report 2023" report has been added to 's offering.
0 kommentar(er)
